By Liz Fowler, executive vice president of programs for The Commonwealth Fund
June 15, 2020
CMM: It’s time to pay attention
By ensuring appropriate use of medications, including gene therapies and personalized medicine, we have the potential to address many of the issues that policymakers have been grappling with for decades. On July 22, GTMRx will be releasing its Blueprint for Change to realize that potential. Register here to receive your copy.
Think about all the time we’ve spent on drug pricing and all the energy we’ve put into trying to control spending on medications in this country. Many of us have been looking for policies and approaches to deliver the right therapy to the right patient at the right time.
Comprehensive medication management (CMM) is a solution that’s been right under our noses.
Speaking for myself, I thought that public policy had already weighed in on medication therapy management. As a congressional staffer, I worked on the Medicare Drug Bill in 2003, and medication therapy management was required for all Part D plans. And then the ACA extended the requirement to all Part D beneficiaries.
Medication therapy management represented a tremendous advancement, but it was just a first step. As I started digging into the research and reading all the studies to prepare for this event, it became apparent there was a lot more work to do. And I became a believer.
Ten years later
It’s not that policymakers hadn’t been thinking about these issues. The ACA led to the creation of several new models of primary care. The Medicare Comprehensive Primary Care Initiative, for instance, improved care coordination and reduced emergency department visits. But it didn’t have a significant impact on health spending—or on the physician experience.
And CMMI—the Center for Medicare and Medicaid Innovation—has made great strides, testing more than 40 new payment models—but only two models have been expanded across Medicare.
Cost containment: A scalpel or a scythe?
There’s a growing call for cost containment, and it’s becoming more difficult to ignore. We’re all paying attention now—and rightly so—to Covid-19. But regardless of what the new normal looks like, Congress will be forced to step in to address Medicare spending. And we all know that when that happens, there will be across the board cuts that don’t discriminate between high- and low-quality providers.
Those of us in Washington health policy circles are watching the horizon, and we know the debate over health costs is coming. We have a limited window to identify solutions that improve patient care, reduce costs and improve outcomes. Improving job satisfaction among physicians should also be a priority.
Enter comprehensive medication management.
So where do we begin?
Structural and attitudinal barriers inhibit the adoption of a systematic approach to appropriate medication use access across the health care continuum. Yes, our payment systems are starting to evolve as we explore new innovations in value-based care, but the fundamentals of our system remain outdated—built on a fee-for-service chassis. As a result, it often discourages coordination across providers. It doesn’t reimburse for certain services or certain providers. I don’t need to enumerate the barriers to those of you who study these issues and know them better than I do.
So where do we begin? We need to demonstrate that the savings are achievable. That’s what carries weight with policymakers.
Is CMM the solution to our broken health care system? By itself, no. Practicing medicine is complex. Managing medications is complex. But I am convinced that comprehensive medication management should be an important part of the solution—and it’s one that hasn’t received enough attention.
It’s time to pay attention. The Blueprint for Change will be an important start.
Fowler served as special assistant to President Barack Obama on health care and economic policy at the National Economic Council. This post is adapted from her keynote remarks to the Feb. 6, 2020 Bipartisan Policy Center and GTMRx event: Get the Medications Right: Innovations in Team-Based Care.